Safety, tolerability, pharmacokinetics, and antiviral activity of the novel core protein allosteric modulator ZM-H1505R (Canocapavir) in chronic hepatitis B patients: a randomized multiple-dose escalation trial
新型核心蛋白变构调节剂ZM-H1505R(卡诺卡韦)在慢性乙型肝炎患者中的安全性、耐受性、药代动力学和抗病毒活性:一项随机多剂量递增试验
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-023-02814-w
Jia, Haiyan; Mai, Jiajia; Wu, Min; Chen, Hong; Li, Xiaojiao; Li, Cuiyun; Liu, Jingrui; Liu, Chengjiao; Hu, Yue; Zhu, Xiaoxue; Jiang, Xiuhong; Hua, Bo; Xia, Tian; Liu, Gang; Deng, Aiyun; Liang, Bo; Guo, Ruoling; Lu, Hui; Wang, Zhe; Chen, Huanming; Zhang, Zhijun; Zhang, Hong; Niu, Junqi; Ding, Yanhua